Delivery Order SPE2DB20D3103-SPE2DB24FQ4C5
Award Date
9/29/24
Potential Completion Date
10/21/24
Potential Value
$116K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,613.50 firm fixed price delivery order is for the supply of 200-unit vials of BOTOX. The contract has a completion date of January 3, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,971.12 firm fixed-price delivery order is for the supply of 200-unit vials of BOTOX medication. The contract has a completion date of November 8, 2024 and was awarded on October 18, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,095.80, is a delivery order for 4,567,094,075 units of BOTOX 200 unit vials. It is a firm fixed-price contract with a completion date of February 20, 2025. The contract was not designated with a specific set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,328.52, is for the delivery of 200-unit vials of Botox. It is a firm fixed-price delivery order contract with a completion date of December 4, 2024. The contract is not set aside for any specific business type. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract valued at $13,971.12 to Amerisourcebergen Drug Corp for the supply of 200 unit vials of BOTOX. This delivery order contract is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued at up to $999,999,999, for the provision of a wide range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. The...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $42,739.50 firm fixed-price delivery order is for the supply of 200 unit vials of BOTOX, with a performance period ending on July 28, 2025. The contract is not set aside and represents an open competition award. Amerisourcebergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $20,514.96, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 200-unit vials of Botox, a medication used for various medical treatments. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is January 21, 2025. The contract was not designated with a set-aside...
The U.S. Defense Logistics Agency (DLA) awarded a $61,123.65 Firm Fixed Price delivery order contract to Amerisourcebergen Drug Corp, Corporate Office Division, for the supply of 200-unit vials of BOTOX. This award is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen, valued at up to $999,999,999 through December 2025, for delivering a wide range of pharmaceutical and medical supplies to support military treatment programs and...
This federal contract award to Amerisourcebergen Drug Corp (a major pharmaceutical distributor) is a delivery order valued at $1,233.27 for the supply of 100-unit vials of Botox. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of September 6, 2023. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. This contract is likely part of a larger Indefinite Delivery Contract...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 200 unit vials of BOTOX, with a ceiling value of $17,095.80 and a completion date of July 28, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...